ALZHEIMER BETA-AMYLOID PEPTIDE-25-35 - ELECTROSTATIC INTERACTIONS WITH PHOSPHOLIPID-MEMBRANES

被引:177
|
作者
TERZI, E
HOLZEMANN, G
SEELIG, J
机构
[1] UNIV BASEL,BIOCTR,DEPT BIOPHYS CHEM,CH-4056 BASEL,SWITZERLAND
[2] E MERCK AG,D-64271 DARMSTADT,GERMANY
关键词
D O I
10.1021/bi00189a051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of lipids in the aggregation of three Alzheimer model peptides was investigated with circular dichroism spectroscopy and high-sensitivity titration calorimetry under conditions of low ionic strength. In solution, the peptides beta AP(25-35)OH and beta AP(25-35Nle)NH2 exhibit a reversible random-coil reversible arrow beta-sheet (or beta-structured aggregate) transition. Addition of lipid vesicles containing negatively charged lipids shifts the random-coil reversible arrow beta-sheet equilibrium almost completely toward beta-sheet structure, which can be explained by the specific conditions created at the membrane surface: the cationic peptides are attracted to the negatively charged membrane, and the increase in peptide concentration together with the partial alignment of the peptide molecules then facilitates beta-sheet formation. The third peptide, beta AP-(25-35)NH2, also binds to the lipid membrane but was found to adopt an essentially random-coil structure, both with and without lipids. A quantitative characterization of the binding equilibrium was possible with high-sensitivity titration calorimetry. All three peptides exhibited exothermic binding enthalpies which varied between Delta H approximate to-2 kcal/mol for beta AP(25-35)OH and -8 kcal/mol for beta AP(25-35)NH2. The apparent binding constants, calculated with bulk concentrations, were large and varied between 500 and 5 x 10(4) M(-1), depending on the experimental conditions. However, after correction for electrostatic charge effects using the Gouy-Chapman theory, the intrinsic binding constants were found to be constant and much smaller with K similar to 2-10 M(-1). The low intrinsic binding constants exclude significant hydrophobic interactions between the lipid membrane and the three Alzheimer model peptides even though residues 29-35 are considered to be part of a membrane-spanning domain in the full-length precursor protein. The predominance of electrostatic forces was demonstrated by addition of 0.1 M NaCl, which abolished the peptide-lipid interaction.
引用
收藏
页码:7434 / 7441
页数:8
相关论文
共 50 条
  • [1] Interactions of Alzheimer beta-amyloid peptide with phospholipid membranes
    McLaurin, J
    Chakrabartty, A
    [J]. JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S9 - S9
  • [2] Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes
    McLaurin, J
    Chakrabartty, A
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (02): : 355 - 363
  • [3] Conformational Features of Beta-Amyloid Peptide 25–35
    Agaeva G.A.
    Najafova G.Z.
    [J]. Biophysics, 2023, 68 (5) : 712 - 718
  • [4] The interaction of the neurodegenerative fragment of the beta-amyloid peptide with phospholipid membranes
    VanVeen, M
    OShea, P
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) : S547 - S547
  • [5] The neurochemical and behavioral effects of beta-amyloid peptide(25-35)
    Chen, SY
    Wright, JW
    Barnes, CD
    [J]. BRAIN RESEARCH, 1996, 720 (1-2) : 54 - 60
  • [6] THE CA2+ INFLUX INDUCED BY BETA-AMYLOID PEPTIDE-25-35 IN CULTURED HIPPOCAMPAL-NEURONS RESULTS FROM NETWORK EXCITATION
    BRORSON, JR
    BINDOKAS, VP
    IWAMA, T
    MARCUCCILLI, CJ
    CHISHOLM, JC
    MILLER, RJ
    [J]. JOURNAL OF NEUROBIOLOGY, 1995, 26 (03): : 325 - 338
  • [7] Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity
    Hertel, C
    Terzi, E
    Hauser, N
    JakobRotne, R
    Seelig, J
    Kemp, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) : 9412 - 9416
  • [8] Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes
    Terzi, E
    Holzemann, G
    Seelig, J
    [J]. BIOCHEMISTRY, 1997, 36 (48) : 14845 - 14852
  • [9] ACTIVATION OF MACROPHAGES BY ALZHEIMER BETA-AMYLOID PEPTIDE
    KLEGERIS, A
    WALKER, DG
    MCGEER, PL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (02) : 984 - 991
  • [10] Chemical degradation of beta-amyloid [25-35] peptide under physiological conditions
    Jost, K
    Varga, J
    Szabo, Z
    Penke, B
    Zarandi, M
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 141 - 141